NorthWest Biotherapeutics Inc (NWBO)

[gnawkz]

Summary of all financing rounds held in 2014:

1. Nov 2014 - $25 MM from Woodford
2. Nov 2014 - $10 MM from mortgage of UK facility
3. Oct 2014 - $11.5 MM from Existing Private Institutional Placement (this was to cover the remaining $17 MM of the total $32 MM that was suppose to be raised from the Apr 2014 placement but lowered due to drop in PPS.)
4. Aug 2014 - $17.5 MM from Convertible Notes
5. Apr 2014 - $15 MM from New Institutional Investor (a total of $32 MM was promised)

Total amount raised - $79 MM


Significant cash expenses (9 Months):
- Purchase of new UK facility: $21 MM
- Clinical Trials: $45 MM
- G&A (includes Cognate): $10 MM
Total Cash Expenses incurred ... ~$76 MM

Didn't realize NWBO was in such a precarious cash crunch. The 2 most recent rounds of financing were absolutely necessary in order for NWBO to continue on as a going concern.

I think the 10 MM shares issued was absolutely necessary in order to compensate management. It is clear with the bets that NWBO is making, the end game is getting closer, else these folks are just throwing good money after bad.

Woodford has a stellar track record and I believe would not have invested in NWBO unless he believes it is at the end of the road and a significant move will be forthcoming. It would not make sense for Woodford to invest as the cash balance is just far too low for any BioTech to continue as a going concern WITHOUT sales OR MASSIVE future financing to continue operation.

I am going to be trimming my holdings a bit as that cash number is just easy fodder for AF. $1.6 MM on the most recent balance sheet? Really ...